Immediate Impact
42 standout
Citing Papers
The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy
2025 Standout
Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‐Stratification, and Management
2025 Standout
Works of J. Radke being referenced
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| J. Radke | 340 | 14 | 87 | 107 | 12 | 422 | |
| Anne Stucki | 281 | 30 | 81 | 59 | 11 | 386 | |
| Mirjam Klaus | 338 | 11 | 162 | 110 | 10 | 404 | |
| Anna Evans | 304 | 5 | 160 | 151 | 10 | 459 | |
| B M Camitta | 288 | 37 | 40 | 93 | 10 | 405 | |
| April Sorrell | 303 | 19 | 109 | 194 | 18 | 475 | |
| K. A. Sobocinski | 223 | 17 | 133 | 113 | 12 | 477 | |
| Rosa Marı́a Arana-Trejo | 340 | 9 | 85 | 51 | 12 | 397 | |
| E R van Wering | 278 | 12 | 142 | 244 | 14 | 459 | |
| Susan R. Wiersma | 257 | 25 | 135 | 174 | 16 | 510 | |
| TS Gee | 459 | 228 | 184 | 8 | 502 |
All Works
Loading papers...